TEVA
Teva Pharmaceutical Industries
$36.35
−$0.50 (−1.36%)Sep 10, 2026
Key metrics
The numbers that frame TEVA today
- Market cap
- $42.36B
- P/E (TTM)
- 60.0
- EV / FCF
- 41.2
- Gross margin
- 52.5%
- EV / Sales
- 3.2
- ROIC
- 7.8%
- Div yield
- 0%
- Debt / equity
- 2.2
- 52wk Low
- $18.21
- 52wk High
- $38.37
Growth
Revenue and earnings trend for TEVA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about TEVA
Is Teva Pharmaceutical Industries a good buy?
Yes. Teva Pharmaceutical Industries has strong quality and excellent momentum. Both signals support the setup. Growth looks weak, a caveat that does not overturn the setup. We think Teva Pharmaceutical Industries is selling at a fair price.
What is the market capitalization of TEVA?
Teva Pharmaceutical Industries's market capitalization is $42.36B.
What is the P/E ratio for TEVA stock?
Teva Pharmaceutical Industries's current P/E ratio is 60.
What is the 52-week high for TEVA stock?
The 52-week high for Teva Pharmaceutical Industries is $38.37. The current close of $36.35 is 5.3% below that high.
What is the 52-week low for TEVA stock?
The 52-week low for Teva Pharmaceutical Industries is $18.21. The current close of $36.35 is 99.6% above that low.
Does TEVA stock pay dividends?
Teva Pharmaceutical Industries does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for TEVA?
Teva Pharmaceutical Industries's Debt / Equity ratio is 2.18.